Drug Shortage Report for TEVA-LOSARTAN
Report ID | 113791 |
Drug Identification Number | 02357976 |
Brand name | TEVA-LOSARTAN |
Common or Proper name | LOSARTAN 100MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | P Pack 30 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-29 |
Estimated end date | 2020-09-30 |
Actual end date | 2020-08-20 |
Shortage status | Resolved |
Updated date | 2020-08-21 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-08-21 | English | Compare |
v12 | 2020-08-20 | French | Compare |
v11 | 2020-08-20 | English | Compare |
v10 | 2020-07-30 | French | Compare |
v9 | 2020-07-30 | English | Compare |
v8 | 2020-06-04 | French | Compare |
v7 | 2020-06-04 | English | Compare |
v6 | 2020-05-21 | French | Compare |
v5 | 2020-05-21 | English | Compare |
v4 | 2020-05-08 | French | Compare |
v3 | 2020-05-08 | English | Compare |
v2 | 2020-05-01 | French | Compare |
v1 | 2020-05-01 | English | Compare |
Showing 1 to 13 of 13